Page 185 - YORAM RUDY BOOK FINAL

P. 185
79. Tristani-Firouzi M, Sanguinetti MC. Voltage-dependent inactivation of the human K channel
+
KvLQT1 is eliminated by association with minimal K channel (minK) subunits. J Physiol. 1998 Jul
+
1;510 ( Pt 1)(Pt 1):37-45. doi: 10.1111/j.1469-7793.1998.037bz.x. PMID: 9625865; PMCID: PMC2231024.

80. Zagotta WN, Hoshi T, Aldrich RW. Shaker potassium channel gating. III: Evaluation of kinetic

models for activation. J Gen Physiol. 1994 Feb;103(2):321-62. doi: 10.1085/jgp.103.2.321. PMID: 8189208;
PMCID: PMC2216839.

81. Silverman WR, Roux B, Papazian DM. Structural basis of two-stage voltage-dependent

activation in K+ channels. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2935-40. doi: 10.1073/
pnas.0636603100. Epub 2003 Feb 26. PMID: 12606713; PMCID: PMC151444.

82. Koren G, Liman ER, Logothetis DE, Nadal-Ginard B, Hess P. Gating mechanism of a cloned

potassium channel expressed in frog oocytes and mammalian cells. Neuron. 1990 Jan;4(1):39-51.
doi: 10.1016/0896-6273(90)90442-i. PMID: 2310574.

83. Rudy Y. Modelling and imaging cardiac repolarization abnormalities. J Intern Med. 2006

Jan;259(1):91-106. doi: 10.1111/j.1365-2796.2005.01586.x. PMID: 16336517; PMCID: PMC1865512.

84. Nekouzadeh A, Silva JR, Rudy Y. Modeling subunit cooperativity in opening of tetrameric ion
channels. Biophys J. 2008 Oct;95(7):3510-20. doi: 10.1529/biophysj.108.136721. Epub 2008 Jul 11.

PMID: 18621838; PMCID: PMC2547442.

85. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004 Mar
4;350(10):1013-22. doi: 10.1056/NEJMra032426. PMID: 14999113.

86. Sager PT, Gintant G, Turner JR, Pettit S, Stockbridge N. Rechanneling the cardiac
proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium.
Am Heart J. 2014 Mar;167(3):292-300. doi: 10.1016/j.ahj.2013.11.004. Epub 2013 Dec 2. PMID: 24576511.

87. Guo D, Liu Q, Liu T, Elliott G, Gingras M, Kowey PR, Yan GX. Electrophysiological properties
of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human
ventricular myocytes. J Cardiovasc Pharmacol. 2011 Jan;57(1):79-85. doi: 10.1097/FJC.0b013e3181ffe8b3.

PMID: 20980921.

88. Grandi E, Pasqualini FS, Bers DM. A novel computational model of the human
ventricular action potential and Ca transient. J Mol Cell Cardiol. 2010 Jan;48(1):112-21. doi: 10.1016/j.

yjmcc.2009.09.019. Epub 2009 Oct 14. PMID: 19835882; PMCID: PMC2813400.